Interferon-Associated Retinopathy

Archives of Ophthalmology

Volumn 111, Issue 3, 1993, Pages 350-356

  Guyer, David R ^a   Tiedeman, James ^b,i   Yannuzzi, Lawrence A ^a   Slakter, Jason S ^a   Parke, David ^c   Kelley, James ^d   Tang, Rosa A ^e   Marmor, Michael ^f   Abrams, Gary ^g   Miller, Joan W ^h   Gragoudas, Evangelos S ^h  

^a EAR AND THROAT HOSPITAL   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d Greater Baltimore (MD) Medical Center   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f STANFORD UNIVERSITY   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CHOROID VASCULARIZATION; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA EXUDATE; RETINOPATHY; SUBCUTANEOUS DRUG ADMINISTRATION; VISUAL IMPAIRMENT;

ADULT; AGED; CASE REPORT; EYE DISEASES; EYE NEOPLASMS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMAN; INTERFERON TYPE I, RECOMBINANT; ISCHEMIA; MALE; MIDDLE AGE; MONITORING, PHYSIOLOGIC; RETINAL DISEASES; RETINAL VESSELS; SUPPORT, NON-U.S. GOV'T; VISUAL ACUITY;

EID: 0027476959     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1993.01090030068041     Document Type: Article

References (42)

1. 1. Fung WE. Interferon alpha 2a for treatment of age-related macular degeneration. Am J Ophthalmol. 1991;112:349-350.
2. 2. Guyer DR, Adamis AP, Gragoudas ES, Folkman J, Slakter JS, Yannuzi LA. Systemic antiangiogenic therapy for choroidal neovasculariation: what is the role of interferon alfa? Arch Ophthalmol. 1992;110:1383-1384.
3. 3. Quesada JR, Rios A, Swanson D, et al. Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J Clin Oncol. 1985;3:1522-1528.
4. 4. Sertoli MR, Bernengo MG, Ardizzoni A, et al. Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma. Oncology. 1989;46:96-98.
5. 5. Krown SE, Real FX, Cunningham-Rundles S, et al. Preliminary observations of the effects of recombinant leukocyte a interferon in homosexual men with Kaposi's sarcoma. N Engl J Med. 1983;308:1071-1076.
6. 6. Krown SE, Real FX, Krim M, et al. Recombinant leukocyte A interferon in Kaposi's sarcoma. Proc N Y Acad Sci. 1984;437:431-438.
7. 7. Groopman JE, Gottlieb MS, Goodman J, et al. Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with acquired immune deficiency syndrome. Ann Intern Med. 1984;100:671-676.
8. 8. Abrams DI, Volberding PA. Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol. 1986;13:43-47.
9. 9. White CW, Sonheimer HM, Crouch EC, Wilson H, Fan LL. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med. 1989;320:1197-1200.
10. 10. Ezekowitz RAB, Mulliken JB, Folkman JM. Interferon alpha 2a therapy for 'alarming' hemangiomas of infancy. N Engl J Med. In press.
11. 11. Product Information Sheet. Nutley, NJ: Roche Laboratories; 1988.
12. 12. Product Information Sheet. Kenilworth, NJ: Schering Corp; 1988.
13. 13. Jones GJ, Itri L. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients. Cancer. 1986;57:1709-1715.
14. 14. Bauherz G, Soeur M, Lustman F. Oculomotor nerve paralysis induced by alpha II-interferon. Acta Neurol Belg. 1990;90:111-114.
15. 15. Berglund EF, Burton GV, Mills GM, Nichols GM. Hypertrichosis of the eyelashes associated with interferon-alpha therapy for chronic granulocytic leukemia. South Med J. 1990;83:363.
16. 16. Foon KA, Dougher G. Increased growth of eyelashes in a patient given leukocyte A interferon. N Engl J Med. 1984;311:1259.
17. 17. Jacobs AD, Levenson JE, Golde DW. Induction of acute corneal allograft rejection by alpha-2 interferon. Am J Med. 1987;82:181-182.
18. 18. Farkkila M, Iivanainen M, Roine R, et al. Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis. Acta Neurol Scand. 1984;70:42-46.
19. 19. Brouty-Boye D, Zetter B. Inhibition of cell motility by interferon. Science. 1980;108:516-518.
20. 20. Friesel R, Komoriya A, Maciag T. Inhibition of endothelial cell proliferation by gamma interferon. J Cell Biol. 1987;104:689-696.
21. 21. Sidky Y, Borden E. Inhibition of angiogenesis by interferons: effects on tumor and lymphocite-induced vascular responses. Cancer Res. 1987;47:5155-5161.
22. 22. Miller JW, Stinson WG, Folkman J. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology. 1993;100:9-14.
23. 23. Claessens DA, Miller JW, Woods WJ, Folkman J. Alpha-interferon treatment of experiment choroidal neovascularization. Invest Ophthalmol. 1992;33(suppl):1207.
24. 24. Ashton N. Pathological and ultrastructural aspects of the cotton-wool spot. Proc R Soc Med. 1969;62:1271-1275.
25. 25. Orzalesi N, Coghe F. Obstructed axoplasmic transport in Purtscher's traumatic retinopathy. Ophthalmologica. 1980;180:36-45.
26. 26. Brown BC, Shields JA, Sanborn G, et al. Radiation retinopathy. Ophthalmology. 1982:89;1494-1501.
27. 27. Oji EO, McLeod D. Partial central retinal artery occlusion. Trans Ophthalmol Soc U K. 1978;98:156-159.
28. 28. Sinclair SH, Gragoudas ES. Prognosis for rubeosis iridis following central retinal vein occlusion. Br J Ophthalmol. 1979;63:735-743.
29. 29. Brown GC, Brown MM, Hiller T, et al. Cotton-wool spots. Retina. 1985;5:206-214.
30. 30. Gutman I, Walsh JB, Knapp AB. Cotton-wool spots as a sign in leptospirosis (Weil's disease). Ophthalmologica. 1983;187:133-136.
31. 31. Farkas PS, Knapp AB, Leiberman H, et al. Markedly elevated creatinine phosphokinase, cotton-wool spots, and pericarditis in a patient with leptospirosis. Gastroenterology. 1981;80:587-589.
32. 32. Smith TW, Burton TC. The retinal manifestations of Rocky Mountain spotted fever. Am J Ophthalmol. 1977;84:259-262.
33. 33. McFadden DM, Houston CS, Sutton JR, et al. High-altitude retinopathy. JAMA. 1981;245:581-586.
34. 34. Dollery CT. Microcirculatory changes and the cotton-wool spot. Proc R Soc Med. 1969;62:1267-1269.
35. 35. Wise GN, Dollery CT, Henkind P. The Retinal Circulation. New York, NY: Harper & Row; 1971:190-193.
36. 36. Alfano JE, Roper KL. Visual disturbances following acute blood loss. Am J Ophthalmol. 1954;38:817-824.
37. 37. Ferry AP. Retinal cotton-wool spots and cytoid bodies. Mt Sinai J Med. 1972;39:604-609.
38. 38. Ackerman AL. The ocular manifestations of Waldenstrom's macroglubinemia and its treatment. Arch Ophthalmol. 1962;67:701-707.
39. 39. Inkeles DM, Walsh JB. Retinal fat emboli as a sequela to acute pancreatitis. Am J Ophthalmol. 1975;80:935-938.
40. 40. Murphy R. Onchocercal chorioretinitis and its treatment. Presented at the Macula Society; 1985; Marathon, Fla.
41. 41. Conlon KC, Urba WJ, Smith JW, et al. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer. 1990;65:2237-2242.
42. 42. von Wussow P, Freund M, Block B, Diedrich H, Poliwoda H, Deicher H. Clinical significance of anti-IFN-α antibody titers during interferon therapy. Lancet. 1987;2:635-636.